Search for Clinical Trial Results

Hyperplasia - 134 Studies Found
Status | Study |
Enrolling by invitation |
Study Name: Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome Condition: Cushing's Syndrome Date: 2016-01-08 Interventions: Other: No intervention No treatment (intervention) was administered. |
Recruiting |
Study Name: Study of Adrenal Gland Tumors Condition: Adrenal Gland Neoplasm Date: 2000-06-28 |
Recruiting |
Study Name: Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia Condition: Adrenal Hyperplasia, Congenital Date: 2013-01-10 Interventions:
|
Completed |
Study Name: Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia Condition: Adrenal Hyperplasia, Congenital Date: 2007-09-12 Interventions: Drug: Hydrocortisone sodium acetate Subcutaneous administration of medication via insulin pump |
Completed |
Study Name: Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia Condition: Adrenal Hyperplasia, Congenital Date: 2008-06-06 |
Completed |
Study Name: Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers Condition: Adrenal Hyperplasia, Congenital Date: 2008-01-31 |
Completed |
Study Name: Examining Genetic Differences Among People With 21-Hydroxylase Deficiency Condition: 21-hydroxylase Deficiency Date: 2007-10-10 Interventions: Procedure: Hydrocortisone withdrawal This is considered a non-standard treatment. On Day 1, participants |
Completed |
Study Name: Dexamethasone Treatment of Congenital Adrenal Hyperplasia Condition: Adrenal Hyperplasia, Congenital Date: 2008-02-11 Interventions:
|
Active, not recruiting |
Study Name: Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency. Condition:
|
Completed |
Study Name: A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency Condition: 21-hydroxylase Deficiency Date: 2011-11-23 Interventions: Drug: Abiraterone acetate Abiraterone acetate oral suspension administered daily from study Day 1 to stu |